EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells

Yue Qin, Qi Cui, Guihua Sun, Jianfei Chao, Cheng Wang, Xianwei Chen, Peng Ye, Tao Zhou, Arjit Vijey Jeyachandran, Olivia Sun, Wei Liu, Shunyu Yao und 6 weitere

Cell Reports · 2024-11 · 43 (11) · 114867

DOI: 10.1016/j.celrep.2024.114867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-11. Verfasst von Yue Qin und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA. Hauptthemen laut MEDLINE: Killer Cells, Natural, NK Cell Lectin-Like Receptor Subfamily C, Immunotherapy, Pluripotent Stem Cells. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, California Institute for Regenerative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalNK Cell Lectin-Like Receptor Subfamily CImmunotherapyPluripotent Stem CellsGlioblastomaHumansAnimalsMiceCell Line, TumorGene Knockout TechniquesSARS-CoV-2COVID-19HLA-E AntigensXenograft Model Antitumor AssaysCell Differentiation

Stichwörter der Autor:innen

CP: ImmunologyESCsGBMNK cellsNKG2APSCscancer immunotherapyembryonic stem cellsglioblastomaiPSCsimmune checkpointimmunotherapyinduced pluripotent stem cellsleukemiapluripotent stem cells

Substanzen

NK Cell Lectin-Like Receptor Subfamily CKLRC1 protein, humanHLA-E Antigens

Autor:innen und Institutionen

  • Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
  • Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California,…
  • Department of Pathology, City of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
  • Department of Hematology & Hematopoietic Cell Transplantation, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
  • Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA. Electronic address: yshi@coh.org.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • California Institute for Regenerative Medicine
  • National Cancer Institute
  • California Institute of Regenerative Medicine

Zitieren

APA

Qin, Y., Cui, Q., Sun, G., Chao, J., Wang, C., Chen, X., Ye, P., Zhou, T., Jeyachandran, A. V., Sun, O., Liu, W., Yao, S., Palmer, C., Liu, X., Arumugaswami, V., Chan, W. C., Wang, X., & Shi, Y. (2024). Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells. Cell Reports, 43(11), 114867. https://doi.org/10.1016/j.celrep.2024.114867

Vancouver

Qin Y, Cui Q, Sun G, Chao J, Wang C, Chen X, et al. Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells. Cell Reports. 2024;43(11):114867. doi:10.1016/j.celrep.2024.114867

BibTeX
@article{Qin2024,
  author = {Qin, Yue and Cui, Qi and Sun, Guihua and Chao, Jianfei and Wang, Cheng and Chen, Xianwei and Ye, Peng and Zhou, Tao and Jeyachandran, Arjit Vijey and Sun, Olivia and Liu, Wei and Yao, Shunyu and Palmer, Chance and Liu, Xuxiang and Arumugaswami, Vaithilingaraja and Chan, Wing C and Wang, Xiuli and Shi, Yanhong},
  title = {Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {11},
  pages = {114867},
  doi = {10.1016/j.celrep.2024.114867}
}
Kostenlos starten →